Skip to main content

RxSight, Inc. (RXST)

NASDAQ: RXST · IEX Real-Time Price · USD
12.39 -0.12 (-0.96%)
Sep 21, 2021 1:40 PM EDT - Market open
Market Cap328.59M
Revenue (ttm)15.27M
Net Income (ttm)37.27M
Shares Out26.52M
EPS (ttm)1.41
PE Ratio8.82
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume44,781
Open12.61
Previous Close12.51
Day's Range12.39 - 13.08
52-Week Range11.19 - 19.67
Betan/a
Analystsn/a
Price Target20.60 (+66.3%)
Est. Earnings DateNov 15, 2021

About RXST

RxSight is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Our proprietary RxSight Light Adjustable Lens system (“RxSight system”), comprised of our RxSight Light Adjustable Lens (“LAL”), RxSight Light Delivery Device (“LDD”) and accessories, is the first and only commercially available intraocular lens (“IOL”) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. With the RxSight system, the surgeon per...

IndustryMedical Devices
IPO DateJul 30, 2021
CEORon Kurtz, M.D.
Employees171
Stock ExchangeNASDAQ
Ticker SymbolRXST
Full Company Profile

Financial Performance

In 2020, RxSight's revenue was $14.68 million, an increase of 554.98% compared to the previous year's $2.24 million. Earnings were $27.58 million, a decrease of -78.15%.

Financial Statements

News

RxSight Reports Second Quarter 2021 Financial Results

ALISO VIEJO, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today reported finan...

1 week ago - GlobeNewsWire

RxSight Announces Updated Date for Reporting Second Quarter 2021 Financial Results on September 9, 2021

ALISO VIEJO, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., (NASDAQ: RXST) an ophthalmic medical device company, today announced an updated date for reporting second quarter 2021 financial re...

2 weeks ago - GlobeNewsWire

RxSight to Participate in the Wells Fargo Healthcare Conference

ALISO VIEJO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, today announced plans to participate in the upcoming virtual Wells Fargo Health...

3 weeks ago - GlobeNewsWire

RxSight to Report Second Quarter 2021 Financial Results on September 7, 2021

ALISO VIEJO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced that it will report financial results for the second quarter of 2021 after the...

3 weeks ago - GlobeNewsWire

Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI), an early stage platform technology company that promotes oral dosing with its RaniPill, and RxSight, Inc. (NASDAQ:RXST), an ophthalmology-focused MedTech ...

Other symbols:RANI
3 weeks ago - Benzinga

RxSight, Inc. Expands Commercial Leadership with Addition of Steve Everly as Vice-President of U.S. Sales

ALISO VIEJO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company, today announced that Steve Everly has joined the company as its Vice Presiden...

1 month ago - GlobeNewsWire

RxSight Announces Appointments to its Board of Directors

ALISO VIEJO, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company, today announced the appointment of three new members to its Board of Directors effective as of...

1 month ago - GlobeNewsWire

RxSight, Inc. Announces Pricing of Initial Public Offering

RxSight, Inc., an ophthalmic medical device company, today announced the pricing of its initial...

1 month ago - GlobeNewswire

RxSight IPO Registration Document (S-1)

RxSight, Inc. has filed to go public with an IPO on the NASDAQ.

2 months ago - SEC